Bio-Rad Laboratories Class BBIO.B
13F holders, Q2 2025 (June 30)5holders
0new positions
0sold out
$243.52avg. 13F price*
At the end of Q2 2025, 5 institutions reported holding Bio-Rad Laboratories Class B (BIO.B) in their 13F filings, unchanged from Q1 2025. 0 opened new positions and 0 sold out. The largest holders were CSS LLC ($269K), Morgan Stanley ($170K) and Wells Fargo & Company ($41K).
- Company
- Bio-Rad Laboratories Class B
- CUSIP
- 090572108
- Latest filing quarter
- Q2 2026
History
Number of 13F holders
Total Exit/New Position Q1 2025 → Q2 2025
| Institutions | Total Value | |
|---|---|---|
| New Positions | 0 | $0 |
| Exits | 0 | $0 |
All 13F filers, Q1 2025 → Q2 2025: 2 shares bought, net +2 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 5 holders
| CSS LLC | 0.05% | No change | 1,092 | $269K |
| Morgan Stanley | 0.00% | No change | 712 | $170K |
| Wells Fargo & Company | 0.00% | No change | 170 | $41K |
| Whittier Trust Co. | 0.00% | No change | 160 | $40K |
| UBS Group AG | 0.00% | Add +200.0% | 3 | $716 |
"% of holder's portfolio" is BIO.B's weight in each manager's 13F, not the share of Bio-Rad Laboratories Class B the manager owns.